Role of NLRP-3 Inflammasome in Hypertension: A Potential Therapeutic Target.
Pasqua T, Pagliaro P, Rocca C, Angelone T, Penna C.
Curr Pharm Biotechnol. 2018;19(9):708-714. doi: 10.2174/1389201019666180808162011.
Molecular characterization of alterations in the intestinal microbiota of patients with grade 3 hypertension.
Mushtaq N, Hussain S, Zhang S, Yuan L, Li H, Ullah S, Wang Y, Xu J.
Int J Mol Med. 2019 Aug;44(2):513-522. doi: 10.3892/ijmm.2019.4235. Epub 2019 Jun 6.
[Secondary hypertension in women].
Amar L, Azizi M.
Presse Med. 2019 Nov;48(11 Pt 1):1265-1268. doi: 10.1016/j.lpm.2019.07.029. Epub 2019 Nov 13.
Grade of knowledge of hypertension in hypertensive patients.
Estrada D, Sierra C, Soriano RM, Jordán AI, Plaza N, Fernández C; en nombre del equipo investigador.
Enferm Clin (Engl Ed). 2020 Mar-Apr;30(2):99-107. doi: 10.1016/j.enfcli.2018.11.033. Epub 2019 Apr 4.
Prognostic impact of hypertension grading.
Angeli F, Verdecchia P, Reboldi G.
Eur J Intern Med. 2024 Aug;126:83-88. doi: 10.1016/j.ejim.2024.04.008. Epub 2024 Apr 14.
Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation.
Morales Salinas A, Coca A, Olsen MH, Sanchez RA, Sebba-Barroso WK, Kones R, Bertomeu-Martinez V, Sobrino J, Alcocer L, Pineiro DJ, Lanas F, Machado CA, Aguirre-Palacios F, Ortellado J, Perez G, Sabio R, Landrove O, Rodriguez-Leyva D, Duenas-Herrera A, Rodriguez Portelles A, Parra-Carrillo JZ, Piskorz DL, Bryce-Moncloa A, Waisman G, Yano Y, Ventura H, Orias M, Prabhakaran D, Sundström J, Wang J, Burrell LM, Schutte AE, Lopez-Jaramillo P, Barbosa E, Redon J, Weber MA, Lavie CJ, Ramirez A, Ordunez P, Yusuf S, Zanchetti A.
Curr Probl Cardiol. 2017 Jul;42(7):198-225. doi: 10.1016/j.cpcardiol.2017.03.001. Epub 2017 Mar 8.
The incidence of long-term hypertension in children after high-grade renal trauma.
Fuchs ME, Anderson RE, Myers JB, Wallis MC.
J Pediatr Surg. 2015 Nov;50(11):1919-21. doi: 10.1016/j.jpedsurg.2015.05.014. Epub 2015 Jun 3.
Incidence and risk of hypertension associated with PARP inhibitors in cancer patients: a systematic review and meta-analysis.
Chen X, Wen Q, Kou L, Xie X, Li J, Li Y.
BMC Cancer. 2023 Jan 31;23(1):107. doi: 10.1186/s12885-023-10571-5.
Analysis of Medication Prescriptions for Hypertension in a Class 1 and Grade A Hospital in Shanxi Province.
Li Z, Wang S, Ren J, Zhi T, Wang H, Zhu Y, Wang Y, Yao Z, Zhang H, Feng J, Zhang R.
Adv Ther. 2021 Oct;38(10):5100-5115. doi: 10.1007/s12325-021-01869-6. Epub 2021 Aug 19.
Low-grade inflammation and microalbuminuria in hypertension.
Pedrinelli R, Dell'Omo G, Di Bello V, Pellegrini G, Pucci L, Del Prato S, Penno G.
Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2414-9. doi: 10.1161/01.ATV.0000147415.40692.7f. Epub 2004 Oct 14.
